Neuropace, Inc. NPCE EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s EPS (diluted)?
- Neuropace, Inc. (NPCE) reported EPS (diluted) of -$0.20 in Q1 2026.
- How has Neuropace, Inc.'s EPS (diluted) changed year-over-year?
- Neuropace, Inc.'s EPS (diluted) increased by 4.8% year-over-year, from -$0.21 to -$0.20.
- What is the long-term trend for Neuropace, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s EPS (diluted) has grown at a -62.6% compound annual growth rate (CAGR), from -$33.91 to -$0.66.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.